Abnormal bone remodelling in inflammatory arthritis

Canadian Journal of Surgery

Volumn 41, Issue 4, 1998, Pages 264-271

  Bogoch, Earl R ^a   Moran, Erica ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ARTICLE; BIOMECHANICS; BONE ATROPHY; BONE DEFECT; BONE PLATE; BONE REMODELING; BONE STRENGTH; DRUG INDICATION; HUMAN; MATHEMATICAL MODEL; OSTEOPENIA; RHEUMATOID ARTHRITIS;

ANIMALS; ARTHRITIS, RHEUMATOID; BONE AND BONES; BONE DISEASES; BONE REMODELING; BONE RESORPTION; CARTILAGE, ARTICULAR; DIPHOSPHONATES; HUMANS; OSTEOBLASTS; OSTEOCLASTS;

EID: 0031814489     PISSN: 0008428X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Hooyman JR, Melton LJ 3d, Nelson AM, O'Fallon WM, Riggs BL. Fractures after rheumatoid arthritis: a population based study. Arthritis Rheum 1984;27(12);1353-61.
2. Firestein GS. Etiology and pathogenesis of rheumatoid arthritis In: Kelley WN, Harris ED, Ruddy SR, Sledge CB, editors. Textbook of rheumatology. Philadelphia: WB Saunders; 1997. p. 851-97.
3. Gough AKS, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patient with early rheumatoid arthritis [see comment]. Lancet 1994;344:23-7. Comment in: Lancet 1994;344:3-4.
4. Gough AKS, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patient with early rheumatoid arthritis [see comment]. Lancet 1994;344:23-7. Comment in: Lancet 1994;344:3-4.
5. Riggs BL, Melton SJ. The world-wide problem of osteoporosis: insights afforded by epidemiology. Bone 1995;17(5 Suppl):505S-511S.
6. Santer B, Sriratana A, Lowther DA. Carrageenan-induced arthritis: VA morphologic study of the development of inflammation in acute arthritis. Semin Arthritis Rheum 1983;13(2):160-8.
7. Taurog JD, Argentieri DC, McReynolds RA. Adjuvant arthritis. In: Di Sabato G, editor. Immunochemical techniques. Part 1. New York: Academic Press; 1988. p 339-55.
8. Caldwell C, Moran E, Bogoch E. Fractal dimension as a measure of altered trabecular bone in experimental inflammatory arthritis. J Bone Miner Res 1998;13(6):978-85.
9. Lucas S, Bogoch ER, Nespeca R, Grynpas MD. Bone changes induced in a rabbit model of experimental arthritis. Eur J Exp Musculoskelet Res 1993;1:121-9.
10. Swinkels JJ, Bogoch ER, Hearn TC. Bone mineral content and stiffness of trabecular bone of the proximal femur in rheumatoid arthritis and in osteoarthritis [abstract]. Presented at the meeting of the Canadian Orthopaedic Research Society, Quebec, May 25, 1996.
11. Yang JP, Woodside TD, Bogoch ER, Hearn TC. Stiffness of tibial trabecular bone in rheumatoid arthritis of the knee. J Anthroplasty 1997;12(7):798-803.
12. Bellingham CM, Lee JM, Moran EL, Bogoch ER. Torsional properties of the rabbit femoral diaphysis: bisphosphonate prevents arthritis-induced loss of fracture toughness. J Orthop Res 1995;13:876-80.
13. Pysklywec MW, Bogoch ER, Moran EL, Fornasier VL. Altered pore characteristics and geometry in diaphyseal cortical bone affected by inflammatory arthritis. J Orthop Rheumatol 1996;9:150-6.
14. Hajcsar EE, Roberts EM, Moran EL, Grynpas M, Bogoch ER. Osteonal parameters in experimental inflammatory arthritis and treatment with zoledronate in rabbits [abstract]. Presented at the annual meeting of the Canadian Orthopaedic Association, Hamilton, Ont. June 1, 1997.
15. Nesbitt SA, Horton MA. Trafficking of matrix collagens through bone-resorbing osteoclasts. Science 1997;276;266-9.
16. Salo J, Lehenkari P, Mulari M, Metsikkö K, Väänänen H. Removal of osteoclast bone resorption products by transcytosis. Science 1997;276:270-3.
17. Fleisch H. New bisphosphonates in osteoporosis. Osteoporos Int 1993;3(Supp1 2):S15-22.
18. Bogoch ER, Roberts EM, Moran EL, Fornasier VL. Pamidronate prevents rapid bone remodeling and rapid bone loss in experimental inflammatory arthritis. Orthop Trans 1996;19(4):1110-1.
19. Pysklywec MW, Moran EL, Bogoch ER: Zoledronate (CGP 42′446), a bisphosphonate, protects against metaphyseal intracortical defects in experimental inflammatory arthritis. J Orthop Res 1997;15:858-61.
20. Bogoch ER, Moran EL, Roberts EM, Fornasier VL. Bisphosphonate CGP 42′446 reduces cartilage destruction in experimental inflammatory arthritis [abstract]. Presented at the annual meeting of the Canadian Orthopaedic Research Society, Quebec, May 25, 1996.
21. van der Sluijs JA, Geesink RG, van der Linden AJ, Bulstra SK, Kuyer R, Drukker J. The reliability of the Mankin score for osteoarthritis. J Orthop Res 1992;10(1):58-61.
22. Fornasier VL, Moran EL, Bogoch ER. The bisphosphonate zoledronate modifies the intraosseous response of cell populations in experimental inflammatory arthritis (EIA). Presented at the annual meeting of the American Society of Bone & Mineral Research, Hamilton, Ont., June 1, 1997.